{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:02:05Z","timestamp":1780426925442,"version":"3.54.1"},"reference-count":40,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>BACKGROUND. Pharyngitis is a common childhood complaint. Current management for children and adolescents includes 1 of 6 strategies, ie, (1) observe without testing or treatment, (2) treat all suspected cases with an antibiotic, (3) treat those with positive throat cultures, (4) treat those with positive rapid tests, (5) treat those with positive rapid tests and those with positive throat cultures after negative rapid tests, or (6) use a clinical scoring measure to determine the diagnosis\/treatment strategy. The sequelae of untreated group A hemolytic streptococcal (GAS) pharyngitis are rare, whereas antibiotic treatment may result in side effects ranging from rash to death. The cost-utility of these strategies for children has not been reported previously.<\/jats:p><jats:p>METHODS. A decision tree analysis incorporating the total cost and health impact of each management strategy was used to determine cost per quality-adjusted life-year ratios. Sensitivity analyses and Monte Carlo simulations assessed the accuracy of the estimates.<\/jats:p><jats:p>RESULTS. From a societal perspective with current Medicaid reimbursements for testing, performing a throat culture for all patients had the best cost-utility. For private insurance reimbursements, rapid antigen testing had the best cost-utility. Observing without testing or treatment had the lowest morbidity rate and highest cost from a societal perspective but the lowest cost from a payer perspective. The model was most sensitive to the incidence of acute rheumatic fever and peritonsillar abscess after untreated GAS pharyngitis. Monte Carlo simulations demonstrated considerable overlap among all of the options except for treating all patients and observing all patients.<\/jats:p><jats:p>CONCLUSIONS. Observing patients with pharyngitis had the lowest morbidity rate. The costs of this option were primarily from parental time lost from work. Before recommending observation rather than treatment of GAS pharyngitis, accurate estimates of the risk of developing acute rheumatic fever and peritonsillar abscess after GAS pharyngitis are needed.<\/jats:p>","DOI":"10.1542\/peds.2005-0879","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:23:43Z","timestamp":1141241023000},"page":"609-619","source":"Crossref","is-referenced-by-count":34,"title":["Diagnosis and Management of Pharyngitis in a Pediatric Population Based on Cost-Effectiveness and Projected Health Outcomes"],"prefix":"10.1542","volume":"117","author":[{"given":"Robert S.","family":"Van Howe","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Michigan State University College of Human Medicine, Marquette, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Louis P.","family":"Kusnier","sequence":"additional","affiliation":[{"name":"Marquette Family Practice Residency Program, Marquette, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2021120820132988200_R1","unstructured":"American Academy of Pediatrics. Red Book: 2003 Report of the Committee on Infectious Diseases. 26rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:576\u2013578"},{"key":"2021120820132988200_R2","doi-asserted-by":"crossref","unstructured":"Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis.\u20082002;35:113\u2013125","DOI":"10.1086\/340949"},{"key":"2021120820132988200_R3","unstructured":"Institute for Clinical Systems Improvement. Health Care Guideline: Acute Pharyngitis. 5th ed. Bloomington, MN: Institute for Clinical Systems Improvement; 2003. Available at: www.icsi.org. Accessed June 6, 2005"},{"key":"2021120820132988200_R4","unstructured":"Vincent MT, Celestin N, Hussain AN. Pharyngitis. Am Family Physician.\u20082004;69:1465\u20131470"},{"key":"2021120820132988200_R5","doi-asserted-by":"crossref","unstructured":"Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med.\u20082001;134:509\u2013517","DOI":"10.7326\/0003-4819-134-6-200103200-00019"},{"key":"2021120820132988200_R6","doi-asserted-by":"crossref","unstructured":"Tsevat J, Kotagal UR. Management of sore throats in children: a cost-effectiveness analysis. Arch Pediatr Adolesc Med.\u20081999;153:681\u2013688","DOI":"10.1001\/archpedi.153.7.681"},{"key":"2021120820132988200_R7","doi-asserted-by":"crossref","unstructured":"Ehrlich JE, Demopoulos BP, Daniel KR Jr, Ricarte MC, Glied S. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from group A streptococcal pharyngitis in a pediatric population. Prev Med.\u20082002;35:250\u2013257","DOI":"10.1006\/pmed.2002.1062"},{"key":"2021120820132988200_R8","doi-asserted-by":"crossref","unstructured":"Neuner JM, Hamel MB, Phillips RS, Bona K, Aronson MD. Diagnosis and management of adults with pharyngitis: a cost-effectiveness analysis. Ann Intern Med.\u20082003;139:113\u2013122","DOI":"10.7326\/0003-4819-139-2-200307150-00011"},{"key":"2021120820132988200_R9","doi-asserted-by":"crossref","unstructured":"Mayes T, Pichichero ME. Are follow-up throat cultures necessary when rapid antigen detection tests are negative for group A streptococci? Clin Pediatr (Phila).\u20082001;40:191\u2013195","DOI":"10.1177\/000992280104000402"},{"key":"2021120820132988200_R10","doi-asserted-by":"crossref","unstructured":"Hirth, RA, Chernew ME, Miller, E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making.\u20082000;20:332\u2013342","DOI":"10.1177\/0272989X0002000310"},{"key":"2021120820132988200_R11","doi-asserted-by":"crossref","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"key":"2021120820132988200_R12","doi-asserted-by":"crossref","unstructured":"Tompkins RK, Burnes DC, Cable WE. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention. Ann Intern Med.\u20081977;86:481\u2013492","DOI":"10.7326\/0003-4819-86-4-481"},{"key":"2021120820132988200_R13","doi-asserted-by":"crossref","unstructured":"deShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA.\u20081997;278:1895\u201318906","DOI":"10.1001\/jama.1997.03550220101014"},{"key":"2021120820132988200_R14","doi-asserted-by":"crossref","unstructured":"Pichichero ME. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins? Pediatr Infect Dis J.\u20081991;10:550\u2013555","DOI":"10.1097\/00006454-199110001-00011"},{"key":"2021120820132988200_R15","doi-asserted-by":"crossref","unstructured":"McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for management of pharyngitis in children and adults. JAMA.\u20082004;291:1587\u20131595","DOI":"10.1001\/jama.291.13.1587"},{"key":"2021120820132988200_R16","doi-asserted-by":"crossref","unstructured":"Webb KH. Does culture confirmation of high-sensitivity rapid streptococcal tests make sense? A medical decision analysis. Pediatrics.\u20081998;101(2). Available at: www.pediatrics.org\/cgi\/content\/full\/101\/2\/e2","DOI":"10.1542\/peds.101.2.e2"},{"key":"2021120820132988200_R17","unstructured":"Medical Economics. Drug Topics Red Book. Montvale, NJ: Medical Economics; 2000"},{"key":"2021120820132988200_R18","unstructured":"Lieu TA, Fleisher GR, Schwartz JS. Cost-effectiveness of rapid latex agglutination testing and throat culture for streptococcal pharyngitis. Pediatrics.\u20081990;85:246\u2013256"},{"key":"2021120820132988200_R19","unstructured":"US Department of Labor Bureau of Labor Statistics. Consumer price index, 2005. Available at: ftp:\/\/ftp.bls.gov\/pub\/special.requests\/cpi\/cpiai.txt. Accessed June 25, 2005"},{"key":"2021120820132988200_R20","doi-asserted-by":"crossref","unstructured":"Kaplan RM, Bush JW, Berry CC. Health status index: category rating versus magnitude estimation for measuring levels of well-being. Med Care.\u20081979;17:501\u2013521","DOI":"10.1097\/00005650-197905000-00005"},{"key":"2021120820132988200_R21","unstructured":"Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Services Res.\u20081988;23:203\u2013235"},{"key":"2021120820132988200_R22","doi-asserted-by":"crossref","unstructured":"Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol.\u20081982;1:61\u201380","DOI":"10.1037\/0278-6133.1.1.61"},{"key":"2021120820132988200_R23","doi-asserted-by":"crossref","unstructured":"Bennicke T, Brochner-Mortensen K, Kjaer E, Skadhange K, Trolle E. Penicillin therapy in acute tonsillitis, phlegmonous tonsillitis and ulcerative tonsillitis. Acta Med Scand.\u20081951;139:253\u2013274","DOI":"10.1111\/j.0954-6820.1951.tb17166.x"},{"key":"2021120820132988200_R24","doi-asserted-by":"crossref","unstructured":"Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat. Cochrane Database Syst Rev.\u20082004;(2):CD000023","DOI":"10.1002\/14651858.CD000023.pub2"},{"key":"2021120820132988200_R25","doi-asserted-by":"crossref","unstructured":"Zwart S, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomized double blind trial of seven days versus three days treatment or placebo in adults. BMJ.\u20082000;320:150\u2013154","DOI":"10.1136\/bmj.320.7228.150"},{"key":"2021120820132988200_R26","doi-asserted-by":"crossref","unstructured":"Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population, I: factors related to attack rates of rheumatic fever. N Engl J Med.\u20081961;265:559\u2013565","DOI":"10.1056\/NEJM196109212651201"},{"key":"2021120820132988200_R27","doi-asserted-by":"crossref","unstructured":"Land MA, Bisno AL. Acute rheumatic fever: a vanishing disease in suburbia. JAMA.\u20081983;249:895\u2013898","DOI":"10.1001\/jama.249.7.895"},{"key":"2021120820132988200_R28","doi-asserted-by":"crossref","unstructured":"Feinstein AR, Wood WF. Spagnuolo M, et al. Rheumatic fever in children and adolescents: a long-term epidemiological study of subsequent prophylaxis, streptococcal infection, and clinical sequelae, VII: cardiac changes and sequelae. Ann Intern Med.\u20081964;60 (suppl):87\u2013123","DOI":"10.7326\/0003-4819-60-2-87"},{"key":"2021120820132988200_R29","doi-asserted-by":"crossref","unstructured":"Hillner BE, Centor RM. What a difference a day makes: a decision analysis of adult streptococcal pharyngitis. J Gen Intern Med.\u20081987;2:244\u2013250","DOI":"10.1007\/BF02596449"},{"key":"2021120820132988200_R30","doi-asserted-by":"crossref","unstructured":"Baker DM, Cooper RM, Rhodes C, Weymouth LA, Dalton HP. Superiority of conventional culture technique over rapid detection of group A Streptococcus by optical immunoassay. Diagn Microbiol Infect Dis.\u20081995;21:61\u201364","DOI":"10.1016\/0732-8893(95)00023-4"},{"key":"2021120820132988200_R31","doi-asserted-by":"crossref","unstructured":"Randolph MR, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr.\u20081985;106:870\u2013875","DOI":"10.1016\/S0022-3476(85)80228-6"},{"key":"2021120820132988200_R32","unstructured":"Dagnelie CF, van der Graaf Y, De Melker RA. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract.\u20081996;46:589\u2013593"},{"key":"2021120820132988200_R33","doi-asserted-by":"crossref","unstructured":"DeMeyere M, Mervielde Y, Verschraegen G, Bogaert M. Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice. Eur J Clin Pharmacol.\u20081992;43:581\u2013585","DOI":"10.1007\/BF02284954"},{"key":"2021120820132988200_R34","doi-asserted-by":"crossref","unstructured":"Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA.\u20081985;253:127\u2013134","DOI":"10.1001\/jama.1985.03350330069024"},{"key":"2021120820132988200_R35","doi-asserted-by":"crossref","unstructured":"Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis.\u20081984;3:10\u201313","DOI":"10.1097\/00006454-198401000-00004"},{"key":"2021120820132988200_R36","doi-asserted-by":"crossref","unstructured":"Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics.\u20082004;113:866\u2013882","DOI":"10.1542\/peds.113.4.866"},{"key":"2021120820132988200_R37","unstructured":"Horder J, Horder E. Illness in general practice. Practice.\u20081954;173:177\u2013187"},{"key":"2021120820132988200_R38","doi-asserted-by":"crossref","unstructured":"Goslings WRO, Valkenberg HA, Bots AW, Lorrier JC. Attack rates of streptococcal pharyngitis, rheumatic fever and glomerulonephritis in the general population: a controlled pilot study of controlled streptococcal pharyngitis in one village. N Engl J Med.\u20081963;268:687\u2013694","DOI":"10.1056\/NEJM196303282681301"},{"key":"2021120820132988200_R39","doi-asserted-by":"crossref","unstructured":"Shulman ST, Gerber MA. So what's wrong with penicillin for strep throat? Pediatrics.\u20082004;113:1816\u20131819","DOI":"10.1542\/peds.113.6.1816"},{"key":"2021120820132988200_R40","doi-asserted-by":"crossref","unstructured":"Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA.\u20081994;271:375\u2013381","DOI":"10.1001\/jama.271.5.375"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/609\/1070420\/zpe00306000609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/609\/1070420\/zpe00306000609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T04:28:16Z","timestamp":1706934496000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/3\/609\/68627\/Diagnosis-and-Management-of-Pharyngitis-in-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0879","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}